MYGN is expected to report earnings to fall 24.48% to -18 cents per share on November 09
Q3'26
Est.
$-0.19
Q2'26
Missed
by $0.19
Q1'26
Missed
by $0.02
Q4'25
Beat
by $0.06
Q3'25
Beat
by $0.01
The last earnings report on July 30 showed earnings per share of -25 cents, missing the estimate of -5 cents. With 293.67K shares outstanding, the current market capitalization sits at 306.08M.
A.I. Advisor
published General Information
General Information
a developer of therapeutic and predictive medicine products
A.I.dvisor indicates that over the last year, MYGN has been loosely correlated with VCYT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if MYGN jumps, then VCYT could also see price increases.
MYGN's RSI Indicator ascends from oversold territory
The RSI Indicator for MYGN moved out of oversold territory on August 19, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 40 similar instances when the indicator left oversold territory. In of the 40 cases the stock moved higher. This puts the odds of a move higher at .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for MYGN just turned positive on August 20, 2026. Looking at past instances where MYGN's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where MYGN advanced for three days, in of 280 cases, the price rose further within the following month. The odds of a continued upward trend are .
MYGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 133 cases where MYGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The Momentum Indicator moved below the 0 level on August 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MYGN as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
MYGN moved below its 50-day moving average on July 31, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for MYGN crossed bearishly below the 50-day moving average on August 03, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MYGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MYGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.007) is normal, around the industry mean (58.245). P/E Ratio (0.000) is within average values for comparable stocks, (155.381). MYGN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.736). MYGN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.007). P/S Ratio (0.372) is also within normal values, averaging (10.493).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MYGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
